USChina Summit Yields Soybean and Rare Earth Deals Tariff Cut Discussions Continue Australia Files Record 14 Billion Lawsuit Against 3M Over PFAS Contamination at Defense Sites Chinas Coal Strategy Powering the Next Phase of Energy Dominance Cresta Launches Synthetic Customers AI Personas Built from Real Conversations to Enhance Enterprise CX Novartis Raises FullYear Sales and Profit Outlook Signaling Strong Operating Momentum Lowenstein Sandler Hires Scott D Fisher to Strengthen MA and Capital Markets Practice DRD Q3 2014 Earnings NarrowerThanExpected Loss as Gold Producer Cuts Costs BZFD Q1 2026 Earnings EPS Misses Estimates Stock Declines BKKT Q1 2026 Earnings Wide EPS Miss Disappoints Revenue Data Withheld SunocoCorp LLC SUNC Q1 2026 Earnings Massive EPS Miss Amidst Limited Disclosure SLB Q1 2026 Earnings EPS Misses Estimates by Narrow Margin Despite Stable Revenue MSDL Q1 2026 Earnings Modest EPS Beat amid Flat Revenue Profile WesBanco Inc WSBC Edges Higher as Stability Returns to Regional Banking Sector Virco Manufacturing VIRC Holds Steady Near Support as Traders Await Catalyst Nordic American Tankers NAT Slips 18 as Resistance Caps NearTerm Upside Columbus Acquisition Corp Rights COLAR Surge 1176 Whats Driving the Recent Rally Protalix BioTherapeutics PLX Consolidates Near Support After Mild Decline Kevin Warsh Set to Be Sworn In as Federal Reserve Chair on Friday SLGL Q4 2025 Earnings EPS Misses Estimates as DevelopmentStage Biotech Reports No Revenue Woodside Energy WDS Holds Steady Near 2175 Amid Mixed Energy Sector Sentiment ORCL Q1 2026 Earnings EPS Beats Estimates as Cloud Momentum Continues Retractable Technologies Q3 2023 Earnings Loss Per Share of 014 Reported Stock Rises Amid Limited Disclosure ACTU Q1 2026 Earnings WiderThanExpected Loss Weighs on Investor Sentiment APLS Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates Newton Golf Company Inc NWTG Q1 2026 Earnings EPS Misses Estimates as Stock Declines Over 8 COCH Q1 2026 Earnings EPS Beats Estimates Despite PreRevenue Status Stock Declines Ernexa Therapeutics ERNA Q3 2023 Earnings Deepening Losses and ClinicalPhase Uncertainty Weigh on Shares